Development of ATR-FTIR spectroscopy for the diagnosis of Alzheimer’s disease using oral buccal cells

Author:

Paraskevaidi Maria1,Karim Salman2,Santos Marfran3,Lima Kassio3,Crean StJohn4

Affiliation:

1. Imperial College London

2. Charnley Fold, Lancashire and South Cumbria NHS Foundation Trust

3. Federal Institute of Science and Technology of Sertão Pernambucano – Campus Floresta

4. University of Central Lancashire (UCLan)

Abstract

Abstract Background: As general ageing increases, a higher global prevalence of dementia increases in likelihood. Alzheimer’s disease is predicted to triple in cases by 2050, becoming a global concern with heavy impact on socio-economic levels. Although numerous biomarkers have been explored, their clinical performance, especially in early stages, is limited. Current diagnostic approaches also necessitate the use of invasive procedures or laborious and expensive imaging techniques. A rapid, low-cost and non-invasive test for the detection of Alzheimer’s disease could be used for the effective identification of individuals that would need referral for further testing. Oral cavity-derived samples, including saliva and buccal mucosal cells, are considered rich sources of biomarkers for Alzheimer’s disease since they can reflect peripheral changes and correlate well with the disease state. Methods: We assessed the potential of attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy as a diagnostic tool for Alzheimer’s disease using oral buccal cells. Findings: After spectroscopic analysis and use of machine learning algorithms, this approach achieved 76% sensitivity and 100% specificity (area under the curve (AUC): 88%) in differentiating patients with Alzheimer’s disease from age-matched healthy controls. Conclusion: We demonstrate that spectroscopic analysis of buccal cells could detect patients with Alzheimer’s disease with high diagnostic accuracy. Such a test has the potential to provide a non‐invasive, rapid and cost-effective alternative to current CSF and blood sampling procedures. An earlier diagnosis of Alzheimer’s disease and timely intervention are expected to impact on the disease progression.

Publisher

Research Square Platform LLC

Reference65 articles.

1. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019;Nichols E;Lancet Glob Health,2022

2. Diagnosing Alzheimer's disease—non-clinicians and computerised algorithms together are as accurate as the best clinical practice;Foy CML;Int J Geriatr Psychiatry,2007

3. Sheikh S, Haque E, Mir SS. Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis 2013; 2013.

4. Oxidative stress signaling in Alzheimer's disease;Su B;Curr Alzheimer Res,2008

5. Influence of Alzheimer Disease Family History and Genetic Risk on Cognitive Performance in Healthy Middle-Aged and Older People;Donix M;Am J Geriatr Psychiatry,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3